NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 287 filers reported holding NOVOCURE LTD in Q3 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,614 | -50.5% | 100 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $3,263 | -45.7% | 100 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $6,013 | -18.0% | 100 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $7,335 | -8.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | +14.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $7,000 | -12.5% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $8,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $8,000 | -20.0% | 100 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $10,000 | -54.5% | 100 | 0.0% | 0.01% | -54.5% |
| Q2 2021 | $22,000 | +69.2% | 100 | 0.0% | 0.01% | +57.1% |
| Q1 2021 | $13,000 | -18.8% | 100 | 0.0% | 0.01% | -30.0% |
| Q4 2020 | $16,000 | +45.5% | 100 | 0.0% | 0.01% | +42.9% |
| Q3 2020 | $11,000 | +37.5% | 100 | 0.0% | 0.01% | +40.0% |
| Q2 2020 | $8,000 | +14.3% | 100 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $7,000 | -12.5% | 100 | 0.0% | 0.01% | +20.0% |
| Q4 2019 | $8,000 | +14.3% | 100 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $7,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 115,479 | $7,302,000 | 11.05% |
| HARTLINE INVESTMENT CORP/ | 335,585 | $21,219,000 | 5.07% |
| Darsana Capital Partners LP | 1,500,000 | $94,845,000 | 3.08% |
| Rhenman & Partners Asset Management AB | 365,899 | $23,136,000 | 2.55% |
| COURAGE CAPITAL MANAGEMENT LLC | 20,000 | $1,265,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 46,599 | $2,946,000 | 2.04% |
| Granite Investment Partners, LLC | 411,659 | $26,029,000 | 1.40% |
| Nicholas Investment Partners, LP | 146,106 | $9,238,000 | 0.85% |
| Baillie Gifford | 8,829,449 | $558,287,000 | 0.59% |
| Cortina Asset Management, LLC | 141,352 | $8,938,000 | 0.55% |